Connecting Sign in

Insider trades appear within seconds, the rest within the hour.

Get alerts

SABSNasdaq

SAB Biotherapeutics, Inc.

Alert me on SABS

0

Insider buys, 6 months

0

Congress trades, 6 months

0

Signals, 6 months

Six months

After each filing

No purchase or sale on this ticker by a member of Congress or an insider yet.

Filings for SABS

42 held · newest 542 held · newest 2

Loading the filings.

See all 42 filings for SABS

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Signal history

No signal for this ticker yet. A signal is written when insider buying here scores one dot or more.

Stakes

22

Jun 30, 2026 Schedule 13G, amended

Perceptive Advisors LLC: 7.3%, 6,627,501 shares

Jun 30, 2026 Schedule 13G, amended

Caligan Partners LP: 8.8%, 7,967,207 shares

Jun 30, 2026 Schedule 13G, amended

Commodore Capital LP: 9.9%, 8,948,170 shares

Jun 30, 2026 Schedule 13G, amended

Vivo Opportunity Fund Holdings, L.P.: 10%, 22,637,108 shares

Jun 30, 2026 Schedule 13G, amended

Woodline Partners LP: 6.8%, 5,455,355 shares

Jun 30, 2026 Schedule 13G, amended

BALYASNY ASSET MANAGEMENT L.P.: 9.4%, 7,225,439 shares

Jun 30, 2026 Schedule 13G

Adage Capital Management, L.P.: 8.4%, 6,405,553 shares

Aug 6, 2026 Schedule 13D, amended

RA Capital Management, L.P.: 9.9%, 9,609,852 shares

Mar 31, 2026 Schedule 13G, amended

Perceptive Advisors LLC: 8.4%, 6,431,743 shares

Mar 31, 2026 Schedule 13G

Caligan Partners LP: 10.4%, 7,697,207 shares

Mar 31, 2026 Schedule 13G

Balyasny Asset Management L.P.: 10%, 5,089,939 shares

Apr 24, 2026 Schedule 13G

Millennium Management LLC: 5.1%, 3,432,153 shares

Mar 19, 2026 Schedule 13D, amended

RA Capital Management, L.P.: 9.9%, 7,311,225 shares

Mar 9, 2026 Schedule 13D, amended

RA Capital Management, L.P.: 9.9%, 5,166,424 shares

Dec 31, 2025 Schedule 13G, amended

BVF PARTNERS L P/IL: 9.1%, 4,761,906 shares

Dec 31, 2025 Schedule 13G, amended

RTW Investments, LP: 3.2%, 1,587,302 shares

Jan 14, 2026 Schedule 13G

Perceptive Advisors LLC: 7.3%, 3,471,861 shares

Sep 30, 2025 Schedule 13G, amended

BVF PARTNERS L P/IL: 10%, 5,167,618 shares

Sep 30, 2025 Schedule 13G

Woodline Partners LP: 9.9%, 7,125,881 shares

Sep 29, 2025 Schedule 13G

Vivo Opportunity Fund Holdings, L.P.: 10%, 25,931,000 shares

Sep 26, 2025 Schedule 13D

RA Capital Management, L.P.: 9.9%, 4,401,500 shares

Sep 26, 2025 Schedule 13G

Commodore Capital LP: 9.9%, 4,522,977 shares

Schedule 13D is filed within 5 business days of crossing 5 percent by an investor who may seek to influence the company. Schedule 13G is filed by a passive holder, and a large institution has up to 45 days after the quarter end.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal

No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters

No lobbying reports on file.